Activin receptor type IIA (ActRIIA) drugs for Pulmonary Arterial Hypertension

2 tracked Activin receptor type IIA (ActRIIA) drugs in the Pulmonary Arterial Hypertension race. The class explanation lives on the Activin receptor type IIA (ActRIIA) page; the full indication pipeline across every mechanism is on the Pulmonary Arterial Hypertension page.

1 approved / phase 41 Phase 1/2

Head-to-head evidence: HS235 vs Sotatercept

The roster

← all Activin receptor type IIA (ActRIIA) drugs